HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marfan syndrome and other systemic disorders with congenital ectopia lentis. A Danish national survey.

Abstract
In order to elucidate demographic and nosologic characteristics of Marfan syndrome (MS) and other systemic disorders associated with congenital ectopia lentis (ECL) in Denmark, a register of affected persons was established in a nationwide retrospective study. Three hundred and forty patients with MS (180M, 160F) were registered. By January 1, 1993, the estimated prevalence rate of MS was 4.6/100,000. An estimated average birth rate of 0.96/10,000 live born was found. The mean age at death was decreased (38 +/- 18 y) mainly due to cardiovascular complications. Correspondingly, a median cumulative probability of survival of 57 y (males) and 58 y (females) was found. Only seven patients with ECL as manifestation of other systemic disorders were diagnosed in the material, i.e. three patients with homocystinuria, two patients with Weill-Marchesani syndrome, and another 2 patients with sulphite oxidase deficiency. In a further 122 cases with ECL a nosologic diagnosis could not be established due to unavailable or insufficient information. This group may comprise patients with MS and other systemic disorders as well as patients with non-systemic ECL. In retrospect, the differential diagnostic activity for patients with congenital ectopia lentis has been insufficient during the last few decades and a common protocol for diagnosis, control and treatment of ECL is needed.
AuthorsJ Fuchs
JournalActa paediatrica (Oslo, Norway : 1992) (Acta Paediatr) Vol. 86 Issue 9 Pg. 947-52 (Sep 1997) ISSN: 0803-5253 [Print] Norway
PMID9343273 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Adult
  • Cause of Death
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Denmark (epidemiology)
  • Ectopia Lentis (epidemiology, genetics, mortality)
  • Female
  • Health Surveys
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Male
  • Marfan Syndrome (epidemiology, genetics, mortality)
  • Middle Aged
  • Registries (statistics & numerical data)
  • Retrospective Studies
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: